ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Pediatric rheumatology"

  • Abstract Number: 0780 • ACR Convergence 2021

    High Adolescent Health Needs and Relationship to Disease in Patients with Childhood-Onset Systemic Lupus Erythematosus

    Chelsea DeCoste1, Paris Moaf1, Lawrence Ng1, Dragana Ostojic-Aitkens1, Fatima Faruq2, Byran Maguire3, Deborah Levy1, Linda Hiraki1, Alene Toulany1 and Andrea Knight4, 1The Hospital for Sick Children, Toronto, ON, Canada, 2University of Toronto, Toronto, ON, Canada, 3Research Institute, The Hospital for Sick Children, Toronto, ON, Canada, 4Hospital for Sick Children, Toronto, ON, Canada

    Background/Purpose: Childhood-onset systemic lupus erythematosus (cSLE), with typical onset in adolescence, is a chronic life-threatening disease. In addition to dealing with cSLE, these adolescents endure…
  • Abstract Number: 1062 • ACR Convergence 2021

    Telemedicine Enriched Care Model to Optimize Care for Patients with Autoinflammatory Diseases

    Lea Oefelein1, Jens Klotsche2, Susanne Benseler3, Jasmin Kuemmerle-Deschner1 and Tatjana Welzel1, 1Pediatric Rheumatology and Autoinflammatory Reference Center, University Children's Hospital Tuebingen, Tuebingen, Germany, 2German Rheumatism Research Center, Berlin, Germany, 3University of Calgary, Calgary, AB, Canada

    Background/Purpose: Autoinflammatory diseases (AID) are severe potentially life-threatening conditions requiring personalized therapy and monitoring which only few expert centers can provide. Long travel distances impede…
  • Abstract Number: 1624 • ACR Convergence 2021

    Patient-Reported Care Utilization, Socioeconomic Status, and Health Status Among Young Adults with JIA

    Emily Smitherman1, Rouba Chahine1, Nicole Bitencourt2, AKM Rahman1, Erica Lawson3 and Joyce Chang4, 1University of Alabama at Birmingham, Birmingham, AL, 2Loma Linda University Medical Center, Redlands, CA, 3University of California San Francisco, San Francisco, CA, 4Boston Children's Hospital, Brookline, MA

    Background/Purpose: Young adulthood is a vulnerable period for individuals with childhood-onset rheumatic diseases, especially the transition from pediatric to adult care. Our objective was to…
  • Abstract Number: 1929 • ACR Convergence 2021

    Metabolomics Identifies Early Mechanisms of Atherogenic Dyslipidaemia in Juvenile-SLE Patients Associated with Inflammation

    George Robinson1, Kirsty Waddington1, Junjie Peng1, Anna Radziszewska1, David Isenberg2, Yiannis Ioannou1, Ines Pineda-Torra1, Coziana Ciurtin1 and Elizabeth Jury1, 1University College London, London, United Kingdom, 2Centre for Rheumatology, University College London, London, United Kingdom

    Background/Purpose: Cardiovascular disease (CVD) is a leading cause of mortality in patients with juvenile-onset systemic lupus erythematosus (JSLE) through atherosclerosis, the build-up of lipids and…
  • Abstract Number: 0657 • ACR Convergence 2021

    Assessing Patient Transition Outcomes from a Large Pediatric Rheumatology Center to Adult Healthcare

    Mary Robichaux1, Bernard Danna2, Monique Maher2, David McDonald1, Kristiana Nasto1, Alexander Alexander1, Ariel Coleman3, Danielle Guffey1 and Tiphanie Vogel1, 1Baylor College of Medicine, Houston, TX, 2Baylor College of Medicine, Texas Children's Hospital, Houston, TX, 3Texas Children's Hospital, Houston, TX

    Background/Purpose: Transitioning children with chronic diseases from pediatric to adult healthcare can be a challenging task, with high morbidity and mortality. In response, we have…
  • Abstract Number: 0781 • ACR Convergence 2021

    Long-Term Follow-up of Juvenile Localized Scleroderma Patients Treated with Methotrexate-Based Standardized Regimens (Consensus Treatment Plans)

    Suzanne Li1, Aaron Thammavongxay2, Maria Ibarra3, Kathryn Torok4, Polly Ferguson5, C Egla Rabinovich6, Robert Fuhlbrigge7, Katie Stewart8, Elena Pope9, Ronald Laxer10, Sandy Hong11, Thomas Mason12, Mara Becker13, Gloria Higgins14, Fatma Dedeoglu15 and for the CARRA Legacy Registry16, 1Hackensack Meridian School of Medicine, Joseph M. Sanzari Children's Hospital, West Orange, NJ, 2Bergen Academies, Hackensack, NJ, 3Children's Mercy Hospital, Kansas City, MO, 4University of Pittsburgh, Pittsburgh, PA, 5University of Iowa Carver College of Medicine, Iowa City, IA, 6Duke Childrens Hospital & Health Center, Durham, NC, 7University of Colorado, Denver, CO, 8UT Southwestern, Dallas, TX, 9Hospital for Sick Kids, Toronto, ON, Canada, 10SickKids, Toronto, ON, Canada, 11University of Iowa Stead Family Children's Hospital, Iowa City, IA, 12Mayo Clinic, Rochester, MN, 13Duke University Medical Center/Duke Clinical Research Institute, Chapel Hill, NC, 14Ohio State University, Columbus, OH, 15Boston Children's Hospital, Boston, MA, 16Childhood Arthritis and Rheumatology Research Alliance, Milwaukee, WI

    Background/Purpose: Juvenile localized scleroderma (jLS) is a rare chronic inflammatory and fibrosing disease associated with a high risk for morbidity in children. Methotrexate (MTX) has…
  • Abstract Number: 1079 • ACR Convergence 2021

    A Multifaceted Approach to Increasing Enrollment and Activation of Pediatric Rheumatology Patient Portal Profiles

    Y. Ingrid Goh1, Ma'Anne Gawaran1, Neelam Walji-Jivraj1, Kristi Whitney2, Christine O'Brien1, Tala El Tal3, Shirley Tse2, Deborah Levy1, Brian Feldman1, Holly Convery1, Audrey Bell-Peter1, Michelle Anderson1, Lynn Spiegel1, Dilan Dissanayake1, Chelsea DeCoste1, Raphael Kraus1, Jayne MacMahon1, Jeanine McColl1, Alaa Shehab1, Paul Tsoukas4, Linda Hiraki1, Andrea Knight4, Elizaveta Limenis1, Rayfel Schneider1, Ruud Verstegen1, Rae Yeung1, Alexa Latourelle1, Leah Moscato1, Alisha Panjwani1 and Ronald Laxer2, 1The Hospital for Sick Children, Toronto, ON, Canada, 2SickKids, Toronto, ON, Canada, 3University of Toronto/Hospital for Sick Children, Toronto, ON, Canada, 4Hospital for Sick Children, Toronto, ON, Canada

    Background/Purpose: Patient portals provide patients and caregivers the opportunity to be more engaged in their healthcare, as it promotes autonomy and encourages patients and caregivers…
  • Abstract Number: 1625 • ACR Convergence 2021

    Clinical Characteristics of Multisystem Inflammatory Syndrome in Children: A Provincial Cohort

    Herman Tam1, Alison Lopez2, Mona Patel2, Jonathan Rayment3, Lori Tucker4 and Catherine Biggs5, 1Stollery Children's Hospital, University of Alberta, Edmonton, AB, Canada, 2British Columbia Children's Hospital, University of British Columbia, Vancouver, BC, Canada, 3British Columbia Children’s Hospital, University of British Columbia, Vancouver, BC, Canada, 4BC Children's Hospital, Vancouver, BC, Canada, 5[email protected], Vancouver, BC, Canada

    Background/Purpose: Multisystem Inflammatory Syndrome in Children (MIS-C) is a post-infectious complication of COVID-19 infection with overlapping features of Kawasaki Disease (KD) and Toxic Shock Syndrome…
  • Abstract Number: PP11 • ACR Convergence 2021

    “Our Arthritis May Be Chronic but We Are Definitely Iconic” – Two Teens Created a National Podcast for Youth with Rheumatic Diseases

    Trishtha Peters1 and Natasha Trehan2, 1University of Ontario, Toronto, ON, Canada, 2University of Ottawa, Toronto, ON, Canada

    Background/Purpose: Trish Peters was diagnosed with JIA at 11. She has been on Methotrexate to lessen disease activity for her knees and hands. She does…
  • Abstract Number: 0658 • ACR Convergence 2021

    ACCORD: A Novel Rheumatology Transition Clinic Structure for Adolescent and Young Adult Patients with Childhood Onset Rheumatic Disease

    Rebecca Overbury1, Kelly Huynh2, Tracy Frech1, John Bohnsack1 and Aimee Hersh1, 1University of Utah, Salt Lake City, UT, 2Intermountain Health Care, Salt Lake City, UT

    Background/Purpose: The transition of health care from Pediatric to Adult providers for adolescents and young adults with childhood onset rheumatic disease continues to be associated…
  • Abstract Number: 0783 • ACR Convergence 2021

    Transmission Disequilibrium Testing Meets Next Generation Sequencing: Applying TDT to Whole Genome Data in Childhood-Onset Systemic Lupus Erythematosus

    Kathleen Vazzana1, Anthony Musolf2, Joan Bailey-Wilson3, Zuoming Deng3, Mariana Kaplan3 and Laura Lewandowski2, 1National Institutes of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH)/Children's National Hospital, Washington, DC, 2NIAMS, NIH, Rockville, MD, 3National Institutes of Health, Bethesda, MD

    Background/Purpose: Systemic lupus erythematosus (SLE) is a systemic autoimmune disorder that is more severe in children than adults. Due to aggressive disease in childhood-onset SLE…
  • Abstract Number: 1110 • ACR Convergence 2021

    Cryopyrin-associated Periodic Syndromes: GOSH and National Amyloidosis Centre Experience

    Ovgu Kul Cinar1, Charalampia Papadopoulou2, Amber Putland1, Karen Wynne1, Helen J Lachmann3, Despina Eleftheriou4 and Paul A. Brogan4, 1Great Ormond Street Hospital NHS Trust, London, United Kingdom, 2UCL Institute of Child Health, and Great Ormond Street Hospital NHS Foundation Trust, Infection, Immunology, and Rheumatology, London, United Kingdom, 3National Amyloidosis Centre, Royal Free Campus, UCL Medical School, London, United Kingdom, 4Great Ormond Street Hospital NHS Trust, UCL GOS Institute of Child Health, Department of Infection, Immunity & Inflammation, London, United Kingdom

    Background/Purpose: CAPS is a rare, heterogenous inflammasomopathy associated with gain-of-function mutations in NLRP3 that encodes cryopyrin. Mutations in NLRP3 result in excessive IL-1ß production that…
  • Abstract Number: 1626 • ACR Convergence 2021

    Use of Total Hip Arthroplasty in Patients Under 21 Years Old: A U.S. Population Analysis

    J. Alex Gibbons1, Cynthia Kahlenberg1, Deanna Jannat-Khah1, Susan Goodman1, Lisa Mandl1, Peter Sculco1, Stuart Goodman2, Mark Figgie1 and Bella Mehta3, 1Hospital for Special Surgery, New York, NY, 2Stanford University, Stanford, CA, 3Hospital for Special Surgery, Weill Cornell Medicine, New York, NY

    Background/Purpose: Total hip arthroplasty (THA) is a treatment option for young patients with severe hip pathology due to congenital, developmental, rheumatologic, traumatic, and other acquired…
  • Abstract Number: 0457 • ACR Convergence 2020

    Improving Pneumococcal Vaccination Rates in Immunosuppressed Rheumatology Patients

    Julia Harris1, Michael Holland2, Emily Fox2, Amy Ivy3, Maria Ibarra2, Cara Hoffart2, Jordan Jones2, Leslie Favier4 and Ashley Cooper2, 1Children's Mercy Kansas City, Overland Park, KS, 2Children's Mercy Kansas City, Kansas City, MO, 3Children's Mercy Kansas City, Kansas City, 4Children's Mercy Kansas City, Leawood, KS

    Background/Purpose: The Centers for Disease Control and Prevention recommends pneumococcal vaccination of high-risk patients, including patients on iatrogenic immunosuppression. Many patients seen in the rheumatology…
  • Abstract Number: 0727 • ACR Convergence 2020

    Hip Involvement Leads to Poor Outcome in Adulthood in Children with Enthesitis Related Arthritis (ERA) Category of Juvenile Idiopathic Arthritis (JIA)

    Naveen R1, Namita Mohindra1, Neeraj Jain1 and Amita Aggarwal2, 1Sanjay Gandhi Post graduate institute of medical sciences, Lucknow, Uttar Pradesh, India, 2Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India

    Background/Purpose: Enthesitis related arthritis (ERA) is the commonest category of JIA seen in India and constitutes 30-40% of all JIA patients. There are many studies…
  • « Previous Page
  • 1
  • …
  • 33
  • 34
  • 35
  • 36
  • 37
  • …
  • 52
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology